Product Program year 2025 Source: CMS Open Payments

Diamondback Peripheral

Device Vascular

PDI 10850000491172

Open in the dashboard

General payments

$521,418

5,838 payments

Research payments

$59,044

8 payments

Through program year 2025, $521,418 in general payments and $59,044 in research payments were reported against Diamondback Peripheral (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $57,561 1,083
2024 General $164,846 2,202
2024 Research $39,745 3
2023 General $299,010 2,553
2023 Research $19,299 5

Breakdown

Who paid General payments · program years 2023–2025
  1. Abbott Laboratories $521,418 5,838 payments
Top recipients General payments · program year 2025
  1. Amr El-Sergany Vascular Surgery · Aiea, HI $6,617 11% · 2 payments
  2. Jose Gonzalez Vascular Surgery · McAllen, TX $3,850 7% · 2 payments
  3. Enrique Hernandez Vila Interventional Cardiology · Ponce, PR $2,672 5% · 7 payments
  4. Kevin Croce Cardiovascular Disease · Chestnut Hill, MA $2,600 5% · 1 payment
  5. Hady Lichaa Cardiovascular Disease · Murfreesboro, TN $2,000 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $18,716 33% · 110 practitioners
  2. Cardiovascular Disease Internal Medicine $10,919 19% · 102 practitioners
  3. Interventional Cardiology Internal Medicine $8,735 15% · 142 practitioners
  4. Vascular & Interventional Radiology Radiology $4,028 7% · 34 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $3,705 7% · 55 practitioners

The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $7,209 13% · 103 recipients
  2. Hawaii $6,680 12% · 4 recipients
  3. Florida $5,621 10% · 66 recipients
  4. Tennessee $5,521 10% · 41 recipients
  5. California $3,996 7% · 66 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,838 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record